MAPT and Alzheimer disease: This was motivated by previous evidence from animal and in vitro studies suggesting that αSyn aggregates exacerbate tau pathophysiology, promoting its hyperphosphorylation [18, 20], fibrillization and spread, thereby potentially contributing to AD progression [27, 28].